135 related articles for article (PubMed ID: 24940587)
1. Reprocessing unsatisfactory ThinPrep papanicolaou tests using a modified SurePath preparation technique.
Randolph ML; Wu HH; Crabtree WN
Cancer Cytopathol; 2014 May; 122(5):343-8. PubMed ID: 24940587
[TBL] [Abstract][Full Text] [Related]
2. The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?
Bentz JS; Rowe LR; Gopez EV; Marshall CJ
Am J Clin Pathol; 2002 Mar; 117(3):457-63. PubMed ID: 11888086
[TBL] [Abstract][Full Text] [Related]
3. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BD Surepath and ThinPrep Pap systems in the processing of mucus-rich specimens.
Kenyon S; Sweeney BJ; Happel J; Marchilli GE; Weinstein B; Schneider D
Cancer Cytopathol; 2010 Oct; 118(5):244-9. PubMed ID: 21113923
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
6. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
Akpolat I; Smith DA; Ramzy I; Chirala M; Mody DR
Cancer; 2004 Jun; 102(3):142-9. PubMed ID: 15211472
[TBL] [Abstract][Full Text] [Related]
7. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
Islam S; West AM; Saboorian MH; Ashfaq R
Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
[TBL] [Abstract][Full Text] [Related]
8. Cytologic features of low-grade squamous intraepithelial lesion in thinprep papanicolaou test slides and conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
Renshaw AA; Dubray-Benstein B; Haja J; Hughes JH;
Arch Pathol Lab Med; 2005 Jan; 129(1):23-5. PubMed ID: 15628904
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
Papillo JL; Zarka MA; St John TL
Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
12. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears.
Negri G; Menia E; Egarter-Vigl E; Vittadello F; Mian C
Cancer; 2003 Dec; 99(6):342-5. PubMed ID: 14681941
[TBL] [Abstract][Full Text] [Related]
13. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
[TBL] [Abstract][Full Text] [Related]
14. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
Cheung AN; Szeto EF; Leung BS; Khoo US; Ng AW
Cancer; 2003 Dec; 99(6):331-5. PubMed ID: 14681939
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CellSolutions BestPrep® automated thin-layer liquid-based cytology Papanicolaou slide preparation and BestCyte® cell sorter imaging system.
Delga A; Goffin F; Kridelka F; Marée R; Lambert C; Delvenne P
Acta Cytol; 2014; 58(5):469-77. PubMed ID: 25277345
[TBL] [Abstract][Full Text] [Related]
16. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system.
Bolick DR; Hellman DJ
Acta Cytol; 1998; 42(1):209-13. PubMed ID: 9479342
[TBL] [Abstract][Full Text] [Related]
17. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and false-positive rate of the cytologic diagnosis of follicular cervicitis: observations from the College of American Pathologists Pap Educational Program.
Auger M; Khalbuss W; Nayar R; Zhao C; Wasserman P; Souers R; Thomas N; Moriarty AT
Arch Pathol Lab Med; 2013 Jul; 137(7):907-11. PubMed ID: 23808462
[TBL] [Abstract][Full Text] [Related]
19. The reporting rates of high-grade squamous intraepithelial lesions and their human papillomavirus testing and histologic follow-up results: A comparison between ThinPrep and SurePath preparations.
Sinclair WD; Gibbons-Fideler IS; Shen R; Li Z
Diagn Cytopathol; 2021 Aug; 49(8):959-963. PubMed ID: 33991062
[TBL] [Abstract][Full Text] [Related]
20. Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears.
Eltabbakh GH; Lipman JN; Mount SL; Morgan A
Gynecol Oncol; 2000 Oct; 79(1):44-9. PubMed ID: 11006029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
